Results 61 to 70 of about 1,229 (138)

Exploring the role of hydrogen peroxide in the immune microenvironment of hypoxic tumors. [PDF]

Clin Transl Radiat Oncol
Geirnaert F, Kerkhove L, Everaert T, Gevaert T, Dufait I, Ridder M.   +5 more
europepmc   +1 more source

Multimodal Therapy in Multidrug-Resistant Prostatitis: A Case Report and Review of the Literature. [PDF]

Cureus
Renaud E, Nagassar RP, Persaud S.
europepmc   +1 more source

Development of ¹⁸F-Fluoromisonidazole Hypoxia PET/CT Diagnostic Interpretation Criteria and Validation of Interreader Reliability, Reproducibility, and Performance. [PDF]

J Nucl Med
Wray R, Mauguen A, Michaud L, Leithner D, Yeh R, Riaz N, Mirtcheva R, Sherman E, Wong R, Humm J, Lee N, Schöder H.   +11 more
europepmc   +1 more source

Equivalent uniform aerobic dose in radiotherapy for hypoxic tumors. [PDF]

Phys Med Biol
Chvetsov AV, Muzi M.
europepmc   +1 more source

Assessment of tumor hypoxia in spontaneous canine tumors after treatment with OMX, a novel H-NOX oxygen carrier, with [¹⁸F]FMISO PET/CT. [PDF]

BMC Vet Res
Choen S, Kent MS, Loucks FA, Winger JA, Zwingenberger AL.   +4 more
europepmc   +1 more source

Tumor Hypoxia on 18F-fluoromisonidazole Positron Emission Tomography and Distant Metastasis From Head and Neck Squamous Cell Carcinoma.

JAMA Netw Open
Gui C, Wray R, Schöder H, Deasy JO, Grkovski M, Humm JL, Wong RJ, Sherman EJ, Riaz N, Lee NY.   +9 more
europepmc   +1 more source

Identifying G6PC3 as a Potential Key Molecule in Hypoxic Glucose Metabolism of Glioblastoma Derived from the Depiction of ¹⁸F-Fluoromisonidazole and ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography. [PDF]

Biomed Res Int
Okamoto M, Yamaguchi S, Sawaya R, Echizenya S, Ishi Y, Kaneko S, Motegi H, Toyonaga T, Hirata K, Fujimura M.   +9 more
europepmc   +1 more source

Hyperthermia and radiotherapy: physiological basis for a synergistic effect. [PDF]

Front Oncol
Righini MF, Durham A, Tsoutsou PG.
europepmc   +1 more source

Nitroimidazoles as hypoxic cell radiosensitizers and hypoxia probes: misonidazole, myths and mistakes. [PDF]

Br J Radiol, 2019
Wardman P.
europepmc   +1 more source

The value of PFS36 as a primary endpoint for radiotherapy trials in patients with LACC: individual patient data from the Chinese NCC and validation from 26 RCTs. [PDF]

J Natl Cancer Cent
Yang X, Zhang Y, Jia S, Yang Y, Zhu J, Li W, Wu L, An J, Huang M.   +8 more
europepmc   +1 more source